We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Microchip (MCHP) Updates Guidance as Markets Start to Reopen
Read MoreHide Full Article
Microchip (MCHP - Free Report) recently provided an update on first-quarter fiscal 2021 outlook.
The company now anticipates fiscal first-quarter consolidated net sales in the range of $1.247-$1.326 billion, or between flat and down 6% sequentially (mid-point of 3%). Notably, per the previous guidance provided in the last earnings call, net sales were expected in the range of $1.2-$1.3 billion. The figure suggested a decline of 2-10% sequentially (mid-point of 6%).
The Zacks Consensus Estimate for revenues is pegged at $1.23 billion, which suggests year-over-year decline of 6.8%.
Moreover, non-GAAP earnings are now projected to be between $1.35 and $1.53 per share, compared with the prior guided range of $1.25-$1.45. The consensus mark for earnings is currently pegged at $1.32, indicating year-over-year decline of 6.4%.
Following the announcement, Microchip stock was up more than 7% in the pre-market trading, on Jun 3. Notably, shares of the company have declined 7.5% on a year-to-date basis compared with the industry’s fall of 8.5%.
Microchip Technology Incorporated Price and Consensus
Per the press release, the company increased its guidance due to better-than-expected performance of its business. Markedly, the company stated that COVID-19 induced supply chain disruptions, mainly in Malaysia and Philippines have slightly softened.
Microchip also noted that customers’ factories in China are now fully operational, while factories in Europe and North America have also started reopening. This has led to a slight recovery in demand for Microchip. The recovery in demand as well as the easing of supply chain disruptions bodes well for Microchip’s top-line growth.
The company is also likely to benefit from growing demand for 8-bit, 16-bit and 32-bit microcontrollers as well as its memory and analog products. Additionally, improving demand across data center, office equipment and communication infrastructure end-markets augur well.
Moreover, Microchip's expanding product portfolio driven by its strong product roll outs will likely help it acquire more customers and sustain its leading position in the market. Recently, the company launched the Switchtec PAX Advanced Fabric Gen 4 PCIe switch family, which features significant performance improvements and lower latency over legacy PCIe switches.
Further, strength in medical end market, driven by growing demand for hospital equipment like ventilators, oxygen monitors, respirators, ultrasound machines and other COVID-19 related items, is anticipated to boost the company’s performance in the upcoming quarters.
Zacks Rank & Key Picks
Microchip currently carries a Zacks Rank #3 (Hold).
Long-term earnings growth rate for Fastly, Bandwidth and Nice is currently pegged at 25%, 13.6% and 10%, respectively.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Image: Bigstock
Microchip (MCHP) Updates Guidance as Markets Start to Reopen
Microchip (MCHP - Free Report) recently provided an update on first-quarter fiscal 2021 outlook.
The company now anticipates fiscal first-quarter consolidated net sales in the range of $1.247-$1.326 billion, or between flat and down 6% sequentially (mid-point of 3%). Notably, per the previous guidance provided in the last earnings call, net sales were expected in the range of $1.2-$1.3 billion. The figure suggested a decline of 2-10% sequentially (mid-point of 6%).
The Zacks Consensus Estimate for revenues is pegged at $1.23 billion, which suggests year-over-year decline of 6.8%.
Moreover, non-GAAP earnings are now projected to be between $1.35 and $1.53 per share, compared with the prior guided range of $1.25-$1.45. The consensus mark for earnings is currently pegged at $1.32, indicating year-over-year decline of 6.4%.
Following the announcement, Microchip stock was up more than 7% in the pre-market trading, on Jun 3. Notably, shares of the company have declined 7.5% on a year-to-date basis compared with the industry’s fall of 8.5%.
Microchip Technology Incorporated Price and Consensus
Microchip Technology Incorporated price-consensus-chart | Microchip Technology Incorporated Quote
Improving Demand Trends Hold Promise
Per the press release, the company increased its guidance due to better-than-expected performance of its business. Markedly, the company stated that COVID-19 induced supply chain disruptions, mainly in Malaysia and Philippines have slightly softened.
Microchip also noted that customers’ factories in China are now fully operational, while factories in Europe and North America have also started reopening. This has led to a slight recovery in demand for Microchip. The recovery in demand as well as the easing of supply chain disruptions bodes well for Microchip’s top-line growth.
The company is also likely to benefit from growing demand for 8-bit, 16-bit and 32-bit microcontrollers as well as its memory and analog products. Additionally, improving demand across data center, office equipment and communication infrastructure end-markets augur well.
Moreover, Microchip's expanding product portfolio driven by its strong product roll outs will likely help it acquire more customers and sustain its leading position in the market. Recently, the company launched the Switchtec PAX Advanced Fabric Gen 4 PCIe switch family, which features significant performance improvements and lower latency over legacy PCIe switches.
Further, strength in medical end market, driven by growing demand for hospital equipment like ventilators, oxygen monitors, respirators, ultrasound machines and other COVID-19 related items, is anticipated to boost the company’s performance in the upcoming quarters.
Zacks Rank & Key Picks
Microchip currently carries a Zacks Rank #3 (Hold).
A few better-ranked stocks worth considering in the broader sector are Fastly, Inc. (FSLY - Free Report) , Bandwidth Inc. (BAND - Free Report) and Nice Ltd. (NICE - Free Report) . All the three stocks flaunt a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term earnings growth rate for Fastly, Bandwidth and Nice is currently pegged at 25%, 13.6% and 10%, respectively.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2020 today >>